태아수종 치료의 최신 지견

키워드

참고문헌 (86)

1. Romero R, "Nonimmune hydrops. In: Prenatal Diagnosis of Congenital Anomalies", pp.413~ (1988), Appleton & Lange
2. Hutchison AA, "Nonimmunologic hydrops fetalis: a review of 61 cases", Obstet Gynecol, 59, pp.347~352 (1982)
3. Anandakumar C, "Direct intrauterine fetal therapy in a case of bronchopulmonary sequestration associated with non-immune hydrops fetalis", Ultrasound Obstet Gynecol, 13, pp.263~265 (1999)
4. Heinonen S, "Etiology and outcome of second trimester non-immunologic fetal hydrops", Acta Obstet Gynecol Scand, 79, pp.15~18 (2000)
5. Nicolaides KH, "The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization", Am J Obstet Gynecol, 152, pp.341~344 (1985)
6. Moise KJ Jr, "abnormal Starling forces cause fetal hydrops in red blood cell alloimmunization?", Am J Obstet Gynecol, 167, pp.907~912 (1992)
7. Berger HM, "Iron overload, free radical damage, and rhesus haemolytic disease", Lancet, 355, pp.933~936 (1990)
8. "Diagnosis and management of Rhesus(Rh) alloimmunization"[URL]
9. Hernandez-Andrade E, "Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops", Ultrasound Obstet Gynecol, 23, pp.442~445 (2004)
10. Detti L, "Longitudinal assessment of the middle cerebral artery peak systolic velocity in healthy fetuses and in fetuses at risk for anemia", Am J Obstet Gynecol, 187, pp.937~939 (2002)
11. Mari G, "Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses", N Engl J Med, 342, pp.9~14 (2000)
12. ACOG practice bulletin, "Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician- gynecologists. American College of Obstetrics and Gynecology", Int J Gynaecol Obstet, 66, pp.63~70 (1999)
13. Bowman JM, "The prevention of Rh immunization", Transfus Med Rev, 2, pp.129~150 (1988)
14. Moise KJ Jr, "Hemolytic disease of the fetus and newborn. In: Maternal fetal medicine", pp.537~561 (2004), Saunders
15. Snyder EL, "Prevention of hemolytic disease of the newborn due to anti-D. Prenatal", perinatal testing and Rh immune globulin administration, 1998, pp.98, 1~6
16. Allan LD, "Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus", J Am Coll Cardiol, 23, pp.1452~1458 (1994)
17. Wilkins I, "Nonimmune hydrops. In: Maternal fetal medicine", pp.563~576 (2004), Saunders
18. Carlson DE, "Prognostic indicators of the resolution of nonimmune hydrops fetalis and survival of the fetus", Am J Obstet Gynecol, 163, pp.1785~1787 (1990)
19. Castillo RA, "Nonimmune hydrops fetalis: clinical experience and factors related to a poor outcome", Am J Obstet Gynecol, 155, pp.812~816 (1986)
20. Allan LD, "Aetiology of non-immune hydrops: the value of echocardiography", Br J Obstet Gynaecol, 93, pp.223~225 (1986)
21. Machin GA, "Hydrops revisited: literature review of 1,414 cases published in the 1980s", Am J Med Genet, 34, pp.366~390 (1989)
22. Simpson JM, "Fetal tachycardias: management and outcome of 127 consecutive cases", Heart, 79, pp.576~581 (1998)
23. Anandakumar C, "Direct fetal therapy for hydrops secondary to congenital atrioventricular heart block", Obstet Gynecol, 87, pp.835~837 (1996)
24. Buyon JP, "In utero identification and therapy of congenital heart block", Lupus, 4, pp.116~121 (1995)
25. Iskaros J, "Outcome of nonimmune hydrops fetalis diagnosed during the first half of pregnancy", Obstet Gynecol, 90, pp.321~325 (1997)
26. Bukowski R, "Hydrops fetalis", Clin Perinatol, 27, pp.1007~1031 (2000)
27. van den Veyver IB, "Detection of intrauterine viral infection using the polymerase chain reaction", Mol Genet Metab, 63, pp.85~95 (1998)
28. Porter HJ, "B19 parvovirus infection of myocardial cells", Lancet, 1, pp.535~536 (1988)
29. Smoleniec JS, "Management of fetal hydrops associated with parvovirus B19 infection", Br J Obstet Gynaecol, 101, pp.1079~1081 (1994)
30. Iwa N, "Cytodiagnosis of parvovirus B19 infection from ascites fluid of hydrops fetalis: report of a case", Diagn Cytopathol, 13, pp.139~141 (1995)
31. Naides SJ, "Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection", Prenat Diagn, 9, pp.105~114 (1989)
32. Antsaklis AJ, "Prenatal diagnosis of fetal primary cytomegalovirus infection", BJOG, 107, pp.84~88 (2000)
33. Nigro G, "Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection", Obstet Gynecol, 94, pp.909~914 (1999)
34. Enders G, "Parvovirus B19 infections in pregnancy", Behring Inst Mitt, pp.74~78 (1990)
35. Sahakian V, "Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection", Am J Obstet Gynecol, 164, pp.1090~1091 (1991)
36. Peters MT, "Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection", Obstet Gynecol, 75, pp.501~504 (1990)
37. Barron SD, "Infectious causes of hydrops fetalis", Semin Perinatol, 19, pp.493~501 (1995)
38. Forouzan I, "Hydrops fetalis: recent advances", Obstet Gynecol Surv, 52, pp.130~138 (1997)
39. Weiner CP, "Risk factors for cordocentesis and fetal intravascular transfusion", Am J Obstet Gynecol, 165, pp.1020~1025 (1991)
40. Van Kamp IL, "Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization", Am J Obstet Gynecol, 192, pp.171~177 (2005)
41. Mandelbrot L, "Assessment of fetal blood volume for computer-assisted management of in utero transfusion", Fetal Ther, 9, pp.60~66 (1988)
43. Mesogitis S, "Fetal intravascular transfusion for hydropic disease due to rhesus isoimmunization", Fetal Diagn Ther, 20, pp.431~436 (2005)
44. Rodeck CH, "Long-term in utero drainage of fetal hydrothorax", N Engl J Med, 319, pp.1135~1138 (1988)
45. Petrikovsky BM, "Pleural effusion in aneuploidy", Am J Perinatol, 8, pp.214~216 (1991)
46. Bernaschek G, "Feto-amniotic shunting--report of the experience of four European centres", Prenat Diagn, 14, pp.821~833 (1994)
47. Crombleholme TM, "Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung", J Pediatr Surg, 37, pp.331~338 (2002)
48. Aubard Y, "Primary fetal hydrothorax: A literature review and proposed antenatal clinical strategy", Fetal Diagn Ther, 13, pp.325~333 (1998)
49. Picone O, "Thoracoamniotic shunting for fetal pleural effusions with hydrops", Am J Obstet Gynecol, 191, pp.2047~2050 (2004)
50. Anandakumar C, "Management of non-immune hydrops: 8 years’ experience", Ultrasound Obstet Gynecol, 8, pp.196~200 (1996)
51. Leung WC, "Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios", Ultrasound Obstet Gynecol, 23, pp.154~158 (2004)
52. Fick AL, "Unequal placental sharing and birth weight discordance in monochorionic diamniotic twins", Am J Obstet Gynecol, 195, pp.178~183 (2006)
53. Machin GA, "Doppler sonographic demonstration of arterio-venous anastomosis in monochorionic twin gestation", Ultrasound Obstet Gynecol, 16, pp.214~217 (2000)
54. De Lia JE, "Maternal metabolic abnormalities in twin-to-twin transfusion syndrome at mid-pregnancy", Twin Res, 3, pp.113~117 (2000)
55. Barrea C, "Prenatal cardiovascular manifestations in the twin-to-twin transfusion syndrome recipients and the impact of therapeutic amnioreduction", Am J Obstet Gynecol, 192, pp.892~902 (2005)
56. Luke B, "Monozygotic twinning as a congenital defect and congenital defects in monozygotic twins", Fetal Diagn Ther, 5, pp.61~69 (1990)
57. Luks FI, "Limited prognostic value of a staging system for twin-to- twin transfusion syndrome", Fetal Diagn Ther, 19, pp.301~304 (2004)
58. Taylor MJ, "Validation of the Quintero staging system for twin-twin transfusion syndrome", Obstet Gynecol, 100, pp.1257~1265 (2002)
59. Patten RM, "Pretorius DH. Disparity of amniotic fluid volume and fetal size: problem of the stuck twin--US studies", Radiology, 172, pp.153~157 (1989)
60. "Twin-twin transfusion syndrome"[URL]
61. Bower SJ, "Uterine artery blood flow response to correction of amniotic fluid volume", Am J Obstet Gynecol, 173, pp.502~507 (1995)
62. Hecher K, "Endoscopic laser surgery versus serial amniocenteses in the treatment of severe twin-twin transfusion syndrome", Am J Obstet Gynecol, 180, pp.717~724 (1999)
63. Lenclen R, "Neonatal outcome in preterm monochorionic twins with twin-to- twin transfusion syndrome after intrauterine treatment with amnioreduction or fetoscopic laser surgery: comparison with dichorionic twins", Am J Obstet Gynecol, 196, pp.450.e1~450.e7 (2007)
64. Senat MV, "Endoscopic laser surgery versus serial amnioreduction for severe twin-to- twin transfusion syndrome", N Engl J Med, 351, pp.136~144 (2004)
65. Fisk NM, "Stage-based treatment of twin-twin transfusion syndrome", Am J Obstet Gynecol, 190, pp.1491~1492 (2004)
66. Mari G, "Perinatal morbidity and mortality rates in severe twin-twin transfusion syndrome: results of the International Amnioreduction Registry", Am J Obstet Gynecol, 185, pp.708~715 (2001)
67. Quintero RA, "Stage-based treatment of twin-twin transfusion syndrome", Am J Obstet Gynecol, 188, pp.1333~1340 (2003)
68. Moise KJ Jr, "A randomized trial of amnioreduction versus septostomy in the treatment of twin-twin transfusion syndrome", Am J Obstet Gynecol, 193, pp.701~707 (2005)
69. Challis D, "Cord occlusion techniques for selective termination in monochorionic twins", J Perinat Med, 27, pp.327~338 (1999)
70. Deprest JA, "Bipolar coagulation of the umbilical cord in complicated monochorionic twin pregnancy", Am J Obstet Gynecol, 182, pp.340~345 (2000)
71. Rustico MA, "Managing twins discordant for fetal anomaly", Prenat Diagn, 25, pp.766~771 (2005)
72. Gillan JE, "Congenital ascites as a presenting sign of lysosomal storage disease", J Pediatr, 104, pp.225~231 (1984)
73. Molyneux AJ, "Mucopolysaccharidosis type VII associated with hydrops fetalis: histopathological and ultrastructural features with genetic implications", J Clin Pathol, 50, pp.252~254 (1997)
74. Ginsburg SJ, "Hydrops fetalis due to infantile Gaucher’s disease", J Pediatr, 82, pp.1046~1048 (1973)
75. Groener JE, "Prenatal diagnosis of lysosomal storage diseases using fetal blood", Prenat Diagn, 19, pp.930~933 (1999)
76. "Nonimmune hydrops fetalis"[URL]
77. Lenz S, "A possible prenatal evaluation of renal function by amino acid analysis on fetal urine", Prenat Diagn, 5, pp.259~267 (1985)
78. Eugène M, "Evaluation of postnatal renal function in fetuses with bilateral obstructive uropathies by proton nuclear magnetic resonance spectroscopy", Am J Obstet Gynecol, 170, pp.595~602 (1994)
79. Nakamura K, "A case of peripartum cardiomyopathy with a transient increase of plasma interleukin-6 concentration occurred following mirror syndrome", J Perinat Med, 30, pp.426~428 (2002)
80. Vidaeff AC, "Gilstrap LC 3rd, Ramin SM. Mirror syndrome. A case report", J Reprod Med, 47, pp.770~774 (2002)
81. Heyborne KD, "Reversal of Ballantyne syndrome by selective second- trimester fetal termination. A case report", J Reprod Med, 45, pp.360~362 (2000)
82. Stepan H, "Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops", N Engl J Med, 354, pp.1857~1858 (2006)
83. de Crespigny LC, "Fetal abdominal paracentesis in the management of gross fetal ascites", Aust N Z J Obstet Gynaecol, 20, pp.228~230 (1980)
84. Holzgreve W, "Nonimmune hydrops fetalis: diagnosis and management", Semin Perinatol, 9, pp.52~67 (1985)
85. Cumming DC, "Recurrent nonimmune hydrops fetalis", Obstet Gynecol, 54, pp.124~126 (1979)
86. Schwartz SM, "Idiopathic hydrops fetalis report of 4 patients including 2 affected sibs", Am J Med Genet, 8, pp.59~66 (1981)

관련 논문AI추천